Mimosa

Growing, buying or possessing cannabis and seeds is legal only in some places. Check the law where you live before acting on this information.

Overview

Mimosa is a hybrid cannabis cultivar bred and released by Symbiotic Genetics in the late 2010s ^[1]. The strain gained commercial prominence for two qualities: a distinctive citrus-and-stone-fruit aroma that stood apart from the dominant 'gas' and 'cookies' profiles of its era, and high THC levels without the harsher terpene signatures typical of OG-descended lines.

The name references the brunch cocktail, not the tree. The most widely circulated cut is called Mimosa #26, which Symbiotic selected and propagated; many commercial Mimosa products sold today derive from that phenotype or from seed-grown crosses approximating it Weak / limited.

Multiple commercial Mimosa seed lines and phenotypes now exist on the market, some authorized by Symbiotic and others not. Genetic confirmation of which lines are direct descendants of the original #26 cut is limited Weak / limited.

Chemistry

Cannabinoids. Mimosa is a THC-dominant Type I chemotype. Aggregated certificate-of-analysis-coa results from dispensaries commonly report 19–27% total THC, with CBD typically under 0.5% Weak / limited. No peer-reviewed peer-reviewed study has chemotyped Mimosa specifically; these figures are ballpark estimates from commercial testing and should not be treated as fixed specifications.

Terpenes. The dominant terpene profile varies by grower, harvest, and phenotype. Limonene is most frequently reported as the primary terpene, consistent with the citrus aroma, often accompanied by caryophyllene and myrcene as secondary compounds Weak / limited. Some phenotypes express terpinolene dominance, which shifts the aroma toward pine and tropical notes. Total terpene content in well-cured samples typically ranges from 1.5–2.5%.

A critical note: terpene percentages on retail labels vary substantially between laboratories and between harvests of the same clone ^[2]. A single certificate-of-analysis-coa should not be mistaken for the strain's 'standard' profile.

Reported effects

There is no clinical research on Mimosa. Any specific effect claims derive from user anecdotes, aggregated reports on crowdsourced sites, or marketing copy No data.

Users commonly report Mimosa as 'alert and talkative' rather than sedating Anecdote, a description consistent with its limonene-forward, low-myrcene chemistry and high THC. However, claims that it treats anxiety, depression, fatigue, or ADHD are folklore. While THC and limonene each have limited human data on mood and anxiety, those findings do not transfer to predicting the effects of a specific strain ^[3][4].

The indica-sativa-myth — that Mimosa's hybrid or 'sativa-leaning' label predicts daytime or energizing effects — is not supported by chemical analysis of commercial cannabis. Two Mimosa samples from different growers can produce markedly different experiences depending on growing conditions, harvest timing, curing, and individual neurochemistry.

Lineage

Symbiotic Genetics publicly states that Mimosa is Clementine × Purple Punch ^[1]. Clementine is a clone from Crockett Family Farms (itself Tangie × Lemon Skunk), responsible for much of the citrus character; Purple Punch (Larry OG × Granddaddy Purple) contributes dense bud structure and occasional purple coloration in late flower.

This stated lineage is broadly accepted in breeder communities, but several caveats apply:

• 'Clementine' and 'Purple Punch' exist as multiple cuts and seed lines, so the parents represent Symbiotic's specific selections at a specific time, not universal reference plants.
• Many bag-seed and re-bred 'Mimosa' lines now circulating on the gray market are not genetically identical to the original #26 cut Weak / limited.
• Named variants such as Purple Mimosa, Mimosa Evo, or Mimosa Orange Punch are separate crosses or selections, not the original Symbiotic line.
• No public genomic data (e.g., Phylos submissions or Medicinal Genomics profiles) has definitively confirmed or refuted the stated parents Disputed.

Growing Mimosa

Mimosa is considered intermediate in difficulty. Commonly reported characteristics from breeder notes and grower forums Anecdote:

Structure. The plant is medium-tall with lateral branching and responds well to topping and low-stress training. Some phenotypes show significant stretch in early flower.

Flowering time. Typically 9–10 weeks indoors; outdoor harvest in the Northern Hemisphere usually occurs in early-to-mid October.

Yield. Reported as moderate. Commercial growers cite yields around 400–500 g/m² indoors under good conditions; outdoor plants under long-season conditions can produce 500–700 g per plant.

Environment. Prefers moderate humidity (40–50% in flower). Cooler night temperatures in late flower can enhance purple expression in phenotypes that carry that trait. Dense flower structure can trap moisture; strong airflow is important to mitigate mold and bud rot risk.

Pest and disease resistance. Average. No particular resistance or susceptibility has been documented.

Mimosa seeds are available from Symbiotic Genetics and authorized seed partners. Many seeds marketed as Mimosa on the gray market are F2 generations, crosses using the name, or unrelated cultivars Weak / limited.

Marketing vs. reality

Marketing claim: 'Energizing sativa hybrid; perfect for daytime use; combats fatigue and depression; uplifting cerebral high.'

Reality: Mimosa is a high-THC hybrid with a citrus aroma. Whether it feels 'energizing' depends on your tolerance, dose, the specific phenotype, growing and curing conditions, and your own neurochemistry. The 'morning strain' label is brand positioning, not pharmacology.

Marketing claim: 'Mimosa contains X% limonene, the energizing terpene.'

Reality: Limonene percentages vary widely between samples and labs. The idea that any single terpene reliably produces a specific mood effect at the doses present in smoked or vaporized cannabis is not well supported in humans Weak / limited. The 'entourage effect' — the hypothesis that cannabinoids and terpenes work synergistically — is plausible but remains unproven as a mechanism for predicting strain-level outcomes ^[5].

Bottom line: If you enjoy Mimosa's flavour and a particular grower's version works well for you, that is a sound reason to choose it. The name on the jar, however, does not guarantee a specific experience across different batches, grow environments, or individual users.

Frequently asked questions

Is Mimosa an indica, sativa, or hybrid? Mimosa is marketed as a sativa-leaning hybrid. However, the indica-sativa-myth explains why that classification does not reliably predict effects. Two Mimosa samples can produce very different experiences.

What's the typical THC level? Dispensary testing typically shows 19–27% total THC, with CBD under 0.5%. These are aggregated lab reports, not fixed guarantees. Individual samples vary Weak / limited.

How long does Mimosa take to flower? Indoor flowering typically takes 9–10 weeks. Outdoor plants in the Northern Hemisphere usually finish in early-to-mid October Anecdote.

Who bred Mimosa? Symbiotic Genetics bred and released Mimosa in the late 2010s. The stated parentage is Clementine × Purple Punch ^[1].

Sources

How this page was made

Related

• Certificate of Analysis (COA) — Lab-issued document reporting cannabinoid potency and contaminant screening for a specific...
• The Indica/Sativa Myth — The popular classification system contradicts genetics, chemistry, and controlled research...